Renaissance Technologies - CALADRIUS BIOSCIENCES INC ownership

CALADRIUS BIOSCIENCES INC's ticker is CLBS and the CUSIP is 128058203. A total of 34 filers reported holding CALADRIUS BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is 2.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CALADRIUS BIOSCIENCES INC
ValueSharesWeighting
Q2 2022$861,000
-20.9%
1,623,580
+7.7%
0.00%0.0%
Q1 2022$1,088,000
-19.2%
1,507,349
-5.8%
0.00%
-50.0%
Q4 2021$1,347,000
-36.8%
1,600,655
-8.4%
0.00%
-33.3%
Q3 2021$2,131,000
-15.3%
1,747,055
+11.8%
0.00%0.0%
Q2 2021$2,516,000
-10.7%
1,562,832
+7.0%
0.00%
-25.0%
Q1 2021$2,818,000
+88.4%
1,460,155
+39.6%
0.00%
+100.0%
Q4 2020$1,496,000
-10.4%
1,045,855
+12.8%
0.00%0.0%
Q3 2020$1,669,000
+9.2%
927,255
+7.9%
0.00%
+100.0%
Q2 2020$1,529,000
+98.8%
858,986
+101.2%
0.00%0.0%
Q1 2020$769,000
-25.6%
426,974
+3.8%
0.00%0.0%
Q4 2019$1,033,000
+1.8%
411,401
+5.0%
0.00%0.0%
Q3 2019$1,015,000
+17.1%
391,851
+3.0%
0.00%0.0%
Q2 2019$867,000
-24.1%
380,336
+20.6%
0.00%0.0%
Q1 2019$1,142,000
+8.7%
315,348
+6.9%
0.00%0.0%
Q4 2018$1,051,000
-36.6%
295,095
+5.1%
0.00%
-50.0%
Q3 2018$1,657,000
-22.2%
280,864
-18.3%
0.00%
+100.0%
Q2 2018$2,131,000
+148.1%
343,615
+133.7%
0.00%0.0%
Q1 2018$859,000
+129.7%
147,052
+38.1%
0.00%
Q4 2017$374,000
-3.6%
106,452
-1.8%
0.00%
Q3 2017$388,000
-21.5%
108,452
+2.1%
0.00%
-100.0%
Q2 2017$494,000
+0.6%
106,252
+8.9%
0.00%0.0%
Q1 2017$491,000
+138.3%
97,552
+34.3%
0.00%
Q4 2016$206,000
+52.6%
72,652
+149.2%
0.00%
Q3 2016$135,00029,1520.00%
Other shareholders
CALADRIUS BIOSCIENCES INC shareholders Q3 2020
NameSharesValueWeighting ↓
Anson Funds Management LP 241,075$345,0000.07%
Virtu Financial LLC 52,599$75,0000.01%
Summit Trail Advisors, LLC 17,730$25,0000.00%
Renaissance Technologies 1,045,855$1,496,0000.00%
ACADIAN ASSET MANAGEMENT LLC 207,218$296,0000.00%
TSFG, LLC 1$1,0000.00%
VANGUARD GROUP INC 342,608$490,0000.00%
UBS Group AG 6,490$9,0000.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 300$00.00%
IFP Advisors, Inc 80$00.00%
View complete list of CALADRIUS BIOSCIENCES INC shareholders